About

Dennis Gregory · Founder, Refract IP PLLC.


Refract IP is a boutique patent practice based in Austin, Texas, focused on life sciences and technology. The firm provides competitive IP analysis, freedom-to-operate assessment, Hatch-Waxman and paragraph IV strategy, and patent landscape work for pharmaceutical and biotechnology companies and for investors conducting IP-informed due diligence.


Dennis Gregory is the founder of Refract IP PLLC. He has over twenty-five years of experience in life-sciences patent litigation, gained primarily at large law firms. Mr. Gregory has represented both brand-name and generic pharmaceutical companies in Hatch-Waxman patent litigation and parallel inter partes reviews across diverse technology areas including IV/oral iron therapy, multiple sclerosis, gout, gastrointestinal and pulmonary disorders, and cancer imaging and chemotherapy. He also has represented medical device manufacturers. Mr. Gregory also has significant experience in advising clients on both patent and non-patent (regulatory) exclusivity, and FDA regulatory matters.


Dennis Gregory · Austin, Texas


  • State Bar of New York
  • State Bar of Texas
  • U.S. District Court for the Southern District of New York
  • U.S. District Court for the Eastern District of New York
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Patent and Trademark Office — Reg. No. 52,967

Refract IP PLLC, a Texas professional limited liability company.


(737) 278-5345

info@refractip.com

PMB 1556 · 10900 Research Blvd Ste 160C · Austin, TX 78759